Show simple item record Hagen, Brad F. Armstrong-Esther, Christopher Ikuta, Roland Williams, Robert J. Le Navenec, Carole-Lynne Aho, Morgan 2007-07-18T21:20:27Z 2007-07-18T21:20:27Z 2005
dc.identifier.citation Hagen, B. et al. (2005). Antipsychotic drug use in Canadian long-term care facilities: Prevalence, and patterns following resident relocation. International Psychogeriatrics, 17, 179-193. en
dc.identifier.issn 1041-6102
dc.description Online edition of journal available from en
dc.description.abstract Background and aims: Data on antipsychotic use were collected in two Canadian long-term care (LTC) facilities. During the one-year study, residents in one facility were relocated to a new facility, allowing examination of the changes in antipsychotic use associated with relocation. Method: A comparative descriptive design was used. Pharmacy and chart data on antipsychotic use were gathered for three separate one-month periods during one year. Data were collected both in a facility experiencing relocation of all residents to a new facility, and in a facility not undergoing relocation. The three one-month data collection periods covered a one-month period before the relocation, immediately after the relocation, and six months after the relocation. Results: In the facility not experiencing relocation, an average of 31.3% of all residents were receiving antipsychotics. Residents in this facility received antipsychotics for an average length of 0.81 years, and 20.8% of all antipsychotic prescriptions reflected dose reductions within six months of the start of the prescription. Only 8.1% of prescriptions had accompanying documentation on the behavioral indication for the use of antipsychotics. A total of 73.4% of all antipsychotics were ‘atypical’ antipsychotics, and 13.5% of all antipsychotic prescriptions were written as ‘p.r.n.’ (as needed). While the use of antipsychotics remained relatively constant in the non-relocation facility (between 30.3% and 33.1% of all residents), the percentage of residents receiving antipsychotics in the facility experiencing a relocation climbed significantly; from 21.5% six months before the move, to 32.6% immediately after the move, to 36.9% six months after the move. Conclusion: These findings, when compared with the U.S. standards on antipsychotic use (OBRA), suggest the need for additional research on antipsychotic use in Canadian LTC facilities. en
dc.language.iso en en
dc.publisher Cambridge University Press en
dc.subject Long-term care en
dc.subject antipsychotic agents en
dc.subject aged en
dc.subject dementia en
dc.subject skilled nursing facilities en
dc.subject nursing homes en
dc.subject drug utilization review en
dc.subject relocation en
dc.subject Parkinson’s disease en
dc.title Antipsychotic drug use in Canadian long-term care facilities: Prevalence, and patterns following resident relocation en
dc.type Article en
dc.publisher.faculty School of Health Sciences en
dc.description.peer-review Yes en
dc.publisher.institution University of Lethbridge en

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search OPUS

Advanced Search


My Account